Alternatives to indicating roflumilast and the chronic obstructive pulmonary disease classification

Arch Bronconeumol. 2012 Sep;48(9):343. doi: 10.1016/j.arbres.2012.02.010. Epub 2012 Apr 21.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Aminopyridines / pharmacology
  • Aminopyridines / therapeutic use*
  • Autoimmunity
  • Benzamides / pharmacology
  • Benzamides / therapeutic use*
  • Bronchodilator Agents / pharmacology
  • Bronchodilator Agents / therapeutic use*
  • Cholinergic Antagonists / pharmacology
  • Cholinergic Antagonists / therapeutic use*
  • Comorbidity
  • Cyclopropanes / pharmacology
  • Cyclopropanes / therapeutic use
  • Drug Synergism
  • Humans
  • Immunocompromised Host
  • Infection Control
  • Inflammation
  • Phosphodiesterase 4 Inhibitors / pharmacology
  • Phosphodiesterase 4 Inhibitors / therapeutic use*
  • Pulmonary Disease, Chronic Obstructive / classification*
  • Pulmonary Disease, Chronic Obstructive / drug therapy
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Smoking / adverse effects
  • Smoking / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Aminopyridines
  • Benzamides
  • Bronchodilator Agents
  • Cholinergic Antagonists
  • Cyclopropanes
  • Phosphodiesterase 4 Inhibitors
  • Tumor Necrosis Factor-alpha
  • Roflumilast